Methicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and chronic-care-facilities: What is the best strategy?

BMC Geriatrics

Volumn 3, Issue , 2003, Pages 1-6

  Minary Dohen, Patrica ^a   Bailly, Pascale ^a   Bertrand, Xavier ^a   Talon, Daniel ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE CARRIER; DISINFECTION; HEALTH CARE FACILITY; HETEROZYGOTE DETECTION; HOSPITAL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; PATIENT CARE; PATIENT SELECTION; REVIEW; SCREENING; STAPHYLOCOCCUS INFECTION;

EID: 2942696318     PISSN: 14712318     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-3-5     Document Type: Review

References (36)

1. Jevons MP: "Celbenin"-resistant staphylococci. Br Med J 1961, 1:124-125.
2. Ayliffe GAJ: The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997, Suppl 1:74-79.
3. Centers for Disease Control: Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR 2002, 51:565-567.
4. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, SENTRY Partcipants Group: Survey of infections due to Staphylococcus species: frequency of occurence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the Sentry Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, Suppl 2:114-132.
5. Voss A, Milatovic D, Wallrauch SC, Rosdahl VT, Braveny I: Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994, 13:50-55.
6. The Microbiology Surveillance Network of Northern France: Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (EBLSE) in northern France: a five-year multicentre incidence study. J Hosp Infect 2002, 52:107-113.
7. Bailly P, Mulin B, Minary P, Talon D, Réseau franc-comtois de lutte contre les infections nosocomiales: Contrôle des infections à Staphylococcus aureus méticillino-résistant dans un CHU: analyse critique des résultats obtenus. Med Mal Infect 1999, 29:178-183.
8. Bertrand X, Floret N, Thouverez M, Talon D: Staphylococcus aureus résistant à la méticilline. Importance et sensibilité aux autres antibiotiques en Franche-Comté en 1998. HygièneS 2000, 8:205-210.
9. Bertrand X, Talon D: Incidence et conséquence thé rapeutiques de la résistance de Staphylococcus aureus en institution gériatrique. Pyrexie 2001, 5:145-148.
10. Comité Technique national des Infections Nosocomiales (CTIN): Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques. Recommandations pour les établissements de santé. Ministère de l'Emploi et de la Solidarité, Secrétariat d'Etat à la Santé et à l'Action sociale. 1999.
11. Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, Hartstein AI, Kauffman CA, Simmons M, Weinstein: Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within hospitals. Infect Control Hosp Epidemiol 1994, 15:105-115.
12. Kauffman CA, Bradley SF, Terpenning MS: Methicillin-resistant Staphylococcus aureus in long-term care facilities. Infect Control Hosp Epidemiol 1990, 11:600-603.
13. O'Sullivan NP, Keane CT: Risk factors for colonization with methicillin-resistant Staphylococcus aureus among nursing home residents. J Hosp Infect 2000, 45:206-210.
14. Talon D, Bertrand X: Methicillin-resistant Staphylococcus aureus in geriatric patients: usefulness of screening in a chronic-care setting. Infect Control Hosp Epidemiol 2001, 22:505-509.
15. Pujol M, Pena C, Pallares R, Ariza J, Ayats J, Dominguez MA, Gudiol F: Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996, 100:509-516.
16. Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R: An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. J Infect Dis 1979, 139:273-287.
17. Boyce JM, Potter-Bynoe G, Chenevert C, King T: Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18:622-627.
18. Talon D: The role of the hospital environment in the epidemiology of multi-resistant bacteria. J Hosp Infect 1999, 43:13-17.
19. Minary P, Marguet C, Devaux V: Risque lié à Staphylococcus aureus méticillinorésistant dans un service de chirurgie septique. Med Mal Infect 1999, 29:27-32.
20. Cookson BD: Methicillin-resistant Staphylococcus aureus in the community: new battlefronts or is the battle lost? Infect Control Hosp Epidemiol 2000, 21:398-403.
21. Cookson BD: Nosocomial antimicrobial resistance surveillance. J Hosp Infect 1999, Suppl. 1:97-103.
22. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL: Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993, 94:313-328.
23. Hospital Infection Society and British Society for Antimicrobial Chemotherapy: Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1990, 16:351-377.
24. Boyce JM: Methicillin-resistant Staphylococcus aureus: a continuing infection control challenge. Eur J Clin Microbiol Infect Dis 1994, 13:45-9.
25. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C: Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with high level of endemic MRSA. Clin Infect Dis 1998, 27:543-550.
26. Talon D, Rouget C, Cailleaux V, Bailly P, Thouverez M, Barale F, Michel-Briand Y: Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive-care unit: efficacy of mupirocin ointment. J Hosp Infect 1995, 30:39-49.
27. Chaix C, Durand-Zzaleski I, Alberti C, Brun-Buisson C: Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999, 282:1745-1751.
28. Leprat R, Humbert P, Talon D, Bertrand X: Le port du masque par les soignants est-il nécessaire lors de la réfection de pansements? Ann Dermato Venereol 2002, 129:1175-1176.
29. Katz S: Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983, 31:721-727.
30. Brun-Buisson C: Chimiodécontamination des réservoirs de bactéries multirésistantes chez les malades et le personnel soignant. XVIe conférence de consensus en réanimation et médecine d'urgence. Paris: ANDEM 1996.
31. Moss B, Squire JR, Topley E: Nose and skin carriage of Staphylococcus aureus in patients receiving penicillin. Lancet 1948, 1:320-325.
32. White A, Smith J: Nasal reservoir as the source of extranasal staphylococci. Antimicrob Agents Chemother 1963, 30:675-83.
33. White A: Relation between quantitative nasal culture and dissemination of staphylococci. J Lab Clin Med 1961, 58:273-277.
34. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP: Elimination of coincident S. aureus nasal and hand carriage with intranasal application of mupirocin ointment. Ann Intern Med 1991, 114:101-106.
35. Watanabe H, Masaki H, Asoh N, Watanabe K, Oishi K, Kobayashi S, Sato A, Sugita R, Nagatake T: Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2001, 39:3775-3777.
36. Irish D, Eltringham I, Teall A, Pickett H, Farelly H, Reith S, Woodford N, Cookson B: Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 1998, 39:19-26.